Treatment of Advanced NSCLC Patients with an Anti-Idiotypic NeuGcGM3-Based Vaccine: Immune Correlates in Long-Term Survivors
2025; Multidisciplinary Digital Publishing Institute; Volume: 13; Issue: 5 Linguagem: Inglês
10.3390/biomedicines13051122
ISSN2227-9059
AutoresZaima Mazorra, Haslen Hassiul Cáceres-Lavernia, Elia Nenínger-Vinageras, Leslie M. Varona-Rodríguez, Carmen Viada, Zuyén González, Nely Rodríguez‐Zhurbenko, Anne‐Christine Thierry, Gisela María Suárez-Formigo, Yendry Ventura‐Carmenate, Petra Baumgaertner, Sara Trabanelli, Camilla Jandus, Tania Crombet,
Tópico(s)Cancer Immunotherapy and Biomarkers
Referência(s)